Results 271 to 280 of about 367,883 (311)

Therapeutic targeting of FOS in mutant TERT cancers through removing TERT suppression of apoptosis via regulating survivin and TRAIL-R2

Proceedings of the National Academy of Sciences of the United States of America, 2021
Reng-Yun Liu, Jie Tan, Xiaopei Shen
exaly  

tert-BUTYL-tert-OCTYLAMINE

Organic Syntheses, 1987
openaire   +1 more source

Di-tert-butylvinylidenecarbene, tetra-tert-butylbutatriene, tetra-tert-butylhexapentaene, and tetrakis(di-tert-butylvinylidene)cyclobutane

Journal of the American Chemical Society, 1971
openaire   +1 more source

Significance of TERT Genetic Alterations and Telomere Length in Hepatocellular Carcinoma

Cancers, 2021
Jeong Won Jang, Soon-Kyu Lee, Pil Soo Sung   +2 more
exaly  

TERT

2020
openaire   +1 more source

tert-Dodecanethiol

2008
MINOZZI, MATTEO, SPAGNOLO, PIERO, NANNI, DANIELE   +2 more
openaire   +2 more sources

tert.-Alkenyl-, tert.-Alkyl Iron Compounds

2001
  +4 more sources

Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner

Cancer Cell, 2018
Ana Xavier-Magalhães, Josie L Hayes, Christof Fellmann   +2 more
exaly  

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

Acta Neuropathologica, 2013
Marc Remke, Vijay Ramaswamy, David J H Shih   +2 more
exaly  

TERT

2006
openaire   +1 more source